Microsoft says Russian, North Korean hackers target vaccine work

Targets were located in Canada, France, India, South Korea and the United States

BOSTON — Microsoft said it has detected attempts by state-backed Russian and North Korean hackers to steal valuable data from leading pharmaceutical companies and vaccine researchers.

It said in a blog post Friday that most of the attacks in recent months were unsuccessful, but provided no information on how many succeeded or how serious those breaches were.

Chinese state-backed hackers have also been targeting vaccine-makers, the U.S. government said in July while announcing criminal charges.

SCAMMERS POSING AS IRS USE CREDIBLE EMAILS TO THREATEN VICTIMS

Microsoft said most of the targets — located in Canada, France, India, South Korea and the United States — were “directly involved in researching vaccines and treatments for COVID-19.” It did not name the targets but said most had vaccine candidates in various stages of clinical trials.

Stephane Bancel, chief executive officer of Moderna, said the company could see emergency approval for its coronavirus vaccine candidate in December. (iStock)

The company identified one of the state-backed hacker groups as Fancy Bear, the Russian military agents who Britain’s National Cyber Security Center said in July were behind such intrusion attempts. Two others were North Korea’s Lazarus Group and a group Microsoft calls Cerium.

HOSPITALS INCREASINGLY TARGETED BY RANSOMWARE ATTACKS, REPORT SAYS

Most of the break-in efforts involved attempts to steal the login credentials of people associated with the targeted organizations. The Lazarus Group posed as job recruiters while Cerium targeted spear-phishing emails that masqueraded as missives from World Health Organization representatives, Microsoft said.

The blog post coincided with an appearance by Microsoft president Brad Smith at an international forum calling on nations to protect health care facilities from cyberattacks. This year, the Paris Peace Forum is taking place online.

CLICK HERE TO READ MORE ON FOX BUSINESS

Optimism about a COVID-19 vaccine has grown since pharmaceutical giant Pfizer announced earlier this week that preliminary data showed its vaccine to be 90% effective.

At the same time, coronavirus cases are surging. In the U.S., deaths per day have soared more than 40% over the past two weeks to an average of more than 1,100, the highest level in three months.

CLICK HERE FOR THE ALL-NEW FOXBUSINESS.COM